Skip to main content

Advertisement

SpringerLink
Log in

Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Little is known about risk factors for the outcome of pulmonary mucormycosis. We summarized characteristics of this rare disease, and systemically explored risk factors for the outcome.

Methods

Ninety-two patients with pulmonary mucormycosis, including 12 patients at Peking Union Medical College Hospital and 80 patients published in 62 articles between 2006 and 2016, were retrospectively analyzed.

Results

The median age was 47.5 years, and the male to female ratio was 2.8:1. Hematological disorders, diabetes mellitus, renal insufficiency and organ transplantation were main underlying conditions. Twelve percent of patients had no underlying diseases. A predilection for involvement of upper lobes was noted, and thick-walled cavity was described in 37.0% of patients on chest computed tomography. Most of the patients were diagnosed by microscopic analysis (95.7%), mainly histopathology; and only a minority were diagnosed by culture of sterile materials (28.3%). The overall mortality rate was 30.4%. Four independent determinants were associated with a better prognosis: hemoptysis (adjusted OR 7.910; 95% CI 1.411–44.342), chronic onset (adjusted OR 25.269, 95% CI 1.654–385.993), treated with medicine (adjusted OR 53.896, 95% CI 3.072–945.561), and treated with surgery (adjusted OR 5.983, 95% CI 1.497–23.918).

Conclusions

Pulmonary mucormycosis is a rare infection with a high mortality. Invasive approach for histopathology and culture are crucial for a definite diagnosis. Acute onset patients had a poorer prognosis, and early treatment with antifungal therapy is imperative. Surgical approach is recommended in appropriate patients for a better outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21:322–9.

    Article  PubMed  CAS  Google Scholar 

  2. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53. https://doi.org/10.1086/432579.

    Article  PubMed  Google Scholar 

  3. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med. 1999;159:1301–9.

    Article  PubMed  CAS  Google Scholar 

  4. Lin E, Moua T, Limper AH. Pulmonary mucormycosis: clinical features and outcomes. Infection. 2017. https://doi.org/10.1007/s15010-017-0991-6.

    Article  PubMed  Google Scholar 

  5. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21. https://doi.org/10.1086/588660.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Vehreschild JJ, Birtel A, Vehreschild MJ, Liss B, Farowski F, Kochanek M, et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol. 2013;39:310 – 24. https://doi.org/10.3109/1040841X.2012.711741.

    Article  PubMed  CAS  Google Scholar 

  7. Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, GR Thompson 3rd. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16:828–37. https://doi.org/10.1016/S1473-3099(16)00071-2. rd et al.

    Article  PubMed  CAS  Google Scholar 

  8. Zhang L, Tian X, Wang P, Zhang H, Feng R. Recurrent pulmonary mucormycosis after lobectomy in a non-smoking patient without predisposing risk factors. Braz J Infect Dis. 2012;16:590–3. https://doi.org/10.1016/j.bjid.2012.10.005.

    Article  PubMed  Google Scholar 

  9. Agarwal R, Kumar V, Gupta D. Pulmonary mucormycosis: two of a kind. Eur J Intern Med. 2006;17:63–5. https://doi.org/10.1016/j.ejim.2005.08.009.

    Article  PubMed  Google Scholar 

  10. Gilman AL, Serrano A, Skelley J, Zwick D. Successful treatment of pulmonary zygomycosis with posaconazole in a recipient of a haploidentical donor stem cell transplant. Pediatr Blood Cancer. 2006;47:959–63. https://doi.org/10.1002/pbc.20572.

    Article  PubMed  Google Scholar 

  11. Paul S, Marty FM, Colson YL. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. Ann Thorac Surg. 2006;82:338–40. https://doi.org/10.1016/j.athoracsur.2005.09.043.

    Article  PubMed  Google Scholar 

  12. Kotoulas C, Psathakis K, Tsintiris K, Sampaziotis D, Karnesis L, Laoutidis G. Pulmonary mucormycosis presenting as Horner’s syndrome. Asian Cardiovasc Thorac Ann. 2006;14:86–7.

    Article  PubMed  Google Scholar 

  13. Chacko B, David VG, Tamilarasi V, Deepti AN, John GT. Pulmonary mucormycosis in a nondiabetic renal allograft recipient successfully managed by medical therapy alone. Transplantation. 2007;83:1656–7. https://doi.org/10.1097/01.tp.0000266581.35950.15.

    Article  PubMed  Google Scholar 

  14. Patel T, Clifton IJ, Kastelik JA, Peckham DG. Concurrent pulmonary zygomycosis and Mycobacterium tuberculosis infection: a case report. J Med Case Rep. 2007;1:17. https://doi.org/10.1186/1752-1947-1-17.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Garg R, Marak RS, Verma SK, Singh J, Sanjay, Prasad R. Pulmonary mucormycosis mimicking as pulmonary tuberculosis: a case report. Lung India. 2008;25(3):129–31. https://doi.org/10.4103/0970-2113.59595.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Alfageme I, Reina A, Gallego J, Reyes N, Torres A. Endobronchial instillations of amphotericin B: complementary treatment for pulmonary mucormycosis. J Bronchol Interv Pulmonol. 2009;16:214–5. https://doi.org/10.1097/LBR.0b013e3181aa2583.

    Article  Google Scholar 

  17. Li JY, Yong TY, Jurisevic CA, Russ GR, Grove DI, Coates PT, et al. Successful treatment of pulmonary mucormycosis in a renal transplant recipient with limited pulmonary reserve by combined medical and surgical therapy. Heart Lung Circ. 2009;18:226–8. https://doi.org/10.1016/j.hlc.2007.12.003.

    Article  PubMed  Google Scholar 

  18. Kimura M, Ito H. Vesicular thick-walled swollen hyphae in pulmonary zygomycosis. Pathol Int. 2009;59:175–8. https://doi.org/10.1111/j.1440-1827.2009.02346.x.

    Article  PubMed  Google Scholar 

  19. Rassaei N, Shilo K, Lewin-Smith MR, Kalasinsky VF, Klassen-Fischer MK, Franks TJ. Deposition of calcium salts in a case of pulmonary zygomycosis: histopathologic and chemical findings. Hum Pathol. 2009;40:1353–7. https://doi.org/10.1016/j.humpath.2009.01.022.

    Article  PubMed  CAS  Google Scholar 

  20. Chakrabarti A, Marak RS, Shivaprakash MR, Gupta S, Garg R, Sakhuja V, et al. Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus. J Clin Microbiol. 2010;48:1965–9. https://doi.org/10.1128/JCM.01272-09.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chung JH, Godwin JD, Chien JW, Pipavath SJ. Case 160: pulmonary mucormycosis. Radiology. 2010;256:667–70. https://doi.org/10.1148/radiol.10081907.

    Article  PubMed  Google Scholar 

  22. Cooke DT, Pagani FD, Kaul DR, Cooke KR, Lau CL, Riddell JT. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole. Mycoses. 2010;53:163–7. https://doi.org/10.1111/j.1439-0507.2008.01666.x.

    Article  PubMed  Google Scholar 

  23. Koshy CG, Shah S, Mammen T. Subcutaneous emphysema of the chest: could it be pulmonary mucormycosis? Thorax. 2010;65:280. https://doi.org/10.1136/thx.2009.115659.

    Article  PubMed  Google Scholar 

  24. Li WF, He C, Liu XF, Wang SY, Qu JL, Lin ZF. A diagnosis neglected for 6 years: report of a misdiagnosed case of pulmonary mucormycosis and review of the literature. Chin Med J (Engl). 2010;123:2480–2.

    Google Scholar 

  25. Maeda H, Kanzaki M, Isaka T, Onuki T. Successful resection of localized pulmonary mucormycosis after bone marrow transplantation using a virtual 3-dimensional pulmonary model on a personal computer. J Thorac Cardiovasc Surg. 2010;140:1434–6. https://doi.org/10.1016/j.jtcvs.2010.05.007.

    Article  PubMed  Google Scholar 

  26. Hua-Ping Z, Jian L, Jing-Bin H, Jie G, Guo-Xin M, Yan-Hong J, et al. Surgical resection and liposomal amphotericin B to treat cavitary pulmonary zygomycosis in a patient with diabetes. Respir Care. 2011;56:1837–9. https://doi.org/10.4187/respcare.01119.

    Article  PubMed  Google Scholar 

  27. Challa S, Uppin SG, Uppin MS, Paul RT, Prayaga AK, Rao MT. Pulmonary zygomycosis: a clinicopathological study. Lung India. 2011;28:25–9. https://doi.org/10.4103/0970-2113.76297.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Liu HC, Jan MS, Lin YC, Lin WL, Wu TC, Huang CN, et al. A rare pulmonary zygomycosis manifested as chronic mediastinitis and bronchial perforation. Eur Respir J. 2011;38:734–5. https://doi.org/10.1183/09031936.00155110.

    Article  PubMed  CAS  Google Scholar 

  29. Dang CJ, Li YJ, Zhan FH, Shang XM. The appearance of pulmonary mucormycosis on FDG PET/CT. Clin Nucl Med. 2012;37:801–3. https://doi.org/10.1097/RLU.0b013e31825ae470.

    Article  PubMed  Google Scholar 

  30. Fitzpatrick MC, Carter BW. Pulmonary mucormycosis complicating cutaneous blastic plasmacytoid dendritic cell neoplasm. Proceedings. 2012;25:287–8.

    Google Scholar 

  31. Kimura M, Nishimura K, Enoki E, Chikugo T, Maenishi O. Chlamydospores of Rhizopus microsporus var. rhizopodiformis in tissue of pulmonary mucormycosis. Mycopathologia. 2012;174:441–50. https://doi.org/10.1007/s11046-012-9560-9.

    Article  PubMed  Google Scholar 

  32. Muqeetadnan M, Rahman A, Amer S, Nusrat S, Hassan S, Hashmi S. Pulmonary mucormycosis: an emerging infection. Case Rep Pulmonol. 2012;2012:120809. https://doi.org/10.1155/2012/120809.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Fernandez JF, Maselli DJ, Simpson T, Restrepo MI. Pulmonary mucormycosis: what is the best strategy for therapy? Respir Care. 2013;58:e60–3. https://doi.org/10.4187/respcare.02106.

    Article  Google Scholar 

  34. Gayathri Devi HJ, Mohan Rao KN, Prathima KM, Moideen R. Pulmonary mucormycosis presenting with vocal cord paralysis. Respir Med Case Rep. 2013;9:15–7. https://doi.org/10.1016/j.rmcr.2013.03.004.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Lee JS, Kim HC, Park SW, So HS, Woo CY, Choi JH, et al. A case of isolated pulmonary mucormycosis in an immunocompetent host. Tuberc Respir Dis. 2013;74:269–73. https://doi.org/10.4046/trd.2013.74.6.269.

    Article  Google Scholar 

  36. Mahadevaiah AH, Rajagopalan N, Patil M, C Shivaprasad. Coinfection of pulmonary mucormycosis and aspergillosis presenting as bilateral vocal cord palsy. BMJ Case Rep. 2013. https://doi.org/10.1136/bcr-2013-009615. 2013.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Okubo Y, Ishiwatari T, Izumi H, Sato F, Aki K, Sasai D, et al. Pathophysiological implication of reversed CT halo sign in invasive pulmonary mucormycosis: a rare case report. Diagn Pathol. 2013;8:82. https://doi.org/10.1186/1746-1596-8-82.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Choo JY, Park CM, Lee HJ, Lee CH, Goo JM, Im JG. Sequential morphological changes in follow-up CT of pulmonary mucormycosis. Diagn Interv Radiol. 2014;20:42–6. https://doi.org/10.5152/dir.2013.13183.

    Article  PubMed  Google Scholar 

  39. Denu RA, Rush PS, Ahrens SE, Westergaard RP. Idiopathic CD4 lymphocytopenia with giant cell arteritis and pulmonary mucormycosis. Med Mycol Case Rep. 2014;6:73–5. https://doi.org/10.1016/j.mmcr.2014.10.002.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kim YI, Kang HC, Lee HS, Choi JS, Seo KH, Kim YH, et al. Invasive pulmonary mucormycosis with concomitant lung cancer presented with massive hemoptysis by huge pseudoaneurysm of pulmonary artery. Ann Thorac Surgy. 2014;98:1832–5. https://doi.org/10.1016/j.athoracsur.2013.12.051.

    Article  Google Scholar 

  41. Kogure Y, Nakamura F, Shinozaki-Ushiku A, Watanabe A, Kamei K, Yoshizato T, et al. Pulmonary mucormycosis with embolism: two autopsied cases of acute myeloid leukemia. Int J Clin Exp Pathol. 2014;7:3449–53.

    PubMed  PubMed Central  Google Scholar 

  42. Panigrahi MK, Manju R, Kumar SV, Toi PC. Pulmonary mucormycosis presenting as nonresolving pneumonia in a patient with diabetes mellitus. Respir Care. 2014;59(12):e201–5. https://doi.org/10.4187/respcare.03205.

    Article  Google Scholar 

  43. Sarkar S, Jash D, Maji A, Maikap MK. Solitary pulmonary nodule: a rare presentation of pulmonary mucormycosis in an immunocompetent adult. Lung India. 2014;31:70–2. https://doi.org/10.4103/0970-2113.125991.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Higo T, Kobayashi T, Yamazaki S, Ando S, Gonoi W, Ishida M, et al. Cerebral embolism through hematogenous dissemination of pulmonary mucormycosis complicating relapsed leukemia. Int J Clin Exp Pathol. 2015;8:13639–42.

    PubMed  PubMed Central  Google Scholar 

  45. Lopez-Pastorini A, Koryllos A, Brockmann M, Windisch W, Stoelben E. Pseudoaneurysm of the pulmonary artery with massive haemoptysis due to an invasive pulmonary mucormycosis. Thorax. 2016;71:199–200. https://doi.org/10.1136/thoraxjnl-2015-207713.

    Article  PubMed  Google Scholar 

  46. Schneidawind D, Nann D, Vogel W, Faul C, Fend F, Horger M, et al. Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis. Transpl Infect Dis. 2012;14:E166–72. https://doi.org/10.1111/tid.12019.

    Article  Google Scholar 

  47. Sharma A, Gupta V, Singh RS, Kakkar N, Singh S, Bambery P. Angioinvasive pulmonary mucormycosis presenting as multiple bilateral pulmonary nodules in a patient without obvious predisposing factors. Singapore Med J. 2008;49:e269–71.

    Google Scholar 

  48. Talebi-Taher M, Alavi Niakou SN, Javad-Mousavi SA, Vaziri M, Iranpour A, Dehghani M. Pulmonary mucormycosis in a patient with chronic rejection of kidney transplant: a case report. Tanaffos. 2015;14:149–52.

    PubMed  PubMed Central  Google Scholar 

  49. Theisen-Toupal J, Rosenthal ES, Kelly E, Zwicker JI, Akuthota P, Roberts DH. Pulmonary zygomycosis in a non-neutropenic patient with myelodysplastic syndrome on lenalidomide. Respir Care. 2012;57:1175–7. https://doi.org/10.4187/respcare.01346.

    Article  PubMed  Google Scholar 

  50. Vercillo MS, Liptay MJ, Seder CW. Early pneumonectomy for pulmonary mucormycosis. Ann Thorac Surg. 2015;99:e67–8. https://doi.org/10.1016/j.athoracsur.2014.11.061.

    Article  Google Scholar 

  51. Vidovic A, Arsic-Arsenijevic V, Tomin D, Djunic I, Jakovic R, Loncar Z, et al. Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case report. J Med Case Rep. 2013;7:263. https://doi.org/10.1186/1752-1947-7-263.

    Article  PubMed  PubMed Central  Google Scholar 

  52. von Scheven R, Lebiedz P, Spieker T, Uekoetter A, Berdel WE, Kessler T. Fulminant invasive pulmonary mucormycosis with Rhizopus oryzae in a patient with severe aplastic anaemia and common variable immunodeficiency. Mycoses. 2012;55:e32–5. https://doi.org/10.1111/j.1439-0507.2011.02119.x.

    Article  Google Scholar 

  53. Wright AJ, Steiner T, Bilawich AM, English JC, Ryan CF. Pulmonary mucormycosis in a patient with Crohn disease on immunosuppressive medications including infliximab. Can J Infect Dis Med Microbiol. 2013;24:67–8.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Yu S, Chen HB. Tuberculosis of lymph node combined with pulmonary mucormycosis. Chin Med J (Engl). 2015;128:2812–4. https://doi.org/10.4103/0366-6999.167363.

    Article  Google Scholar 

  55. Henn A, Mellon G, Benoit H, Roos-Weil D, Jaureguiberry S, Mordant P, et al. Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemia. Scand J Infect Dis. 2014;46:231–4. https://doi.org/10.3109/00365548.2013.866269.

    Article  PubMed  Google Scholar 

  56. Ramachandran L, Dewan S, Kumar V, Wankhade B. Mucormycosis causing pulmonary artery aneurysm. Respir Med Case Rep. 2015;16:71–3. https://doi.org/10.1016/j.rmcr.2015.07.007.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Wang XM, Guo LC, Xue SL, Chen YB. Pulmonary mucormycosis: a case report and review of the literature. Oncol Lett. 2016;11:3049–53. https://doi.org/10.3892/ol.2016.4370.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Economopoulos N, Kelekis D, Papadopoulos A, Kontopoulou C, Brountzos EN. Subclavian artery occlusion and pseudoaneurysm caused by lung apex mucormycosis: successful treatment with transcatheter embolization. Cardiovasc Intervent Radiol. 2007;30:143–5. https://doi.org/10.1007/s00270-005-0328-1.

    Article  PubMed  Google Scholar 

  59. Koyama N, Nagata M, Hagiwara K, Kanazawa M. Survival of a patient with pulmonary Cunninghamella bertholletiae infection without surgical intervention. Respirology. 2008;13:309–11. https://doi.org/10.1111/j.1440-1843.2008.01234.x.

    Article  PubMed  Google Scholar 

  60. Mysorekar VV, Rao SG. Cytomegalovirus pneumonia with pulmonary mucormycosis. Indian J Pathol Microbiol. 2008;51:294–5.

    Article  PubMed  Google Scholar 

  61. Kusaba G, Ohsawa I, Ishii M, Inoshita H, Ohi H, Horikoshi S, et al. Evidence of immunopathological traces in mucormycosis: an autopsy case. Clin Exp Nephrol. 2010;14:396–400. https://doi.org/10.1007/s10157-010-0289-9.

    Article  PubMed  Google Scholar 

  62. Serio B, Rosamilio R, Giudice V, Zeppa P, Esposito S, Fontana R, et al. Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report. Infez Med. 2012;20:43–7.

    PubMed  Google Scholar 

  63. Ye W, Wang Y, Wen Y, Li H, Li X. Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy. Int Urol Nephrol. 2014;46:1247–51. https://doi.org/10.1007/s11255-013-0628-3.

    Article  PubMed  Google Scholar 

  64. Peixoto D, Hammond SP, Issa NC, Madan R, Gill RR, Milner DA, et al. Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung disease. Open Forum Infect Dis. 2014;1:ofu014. https://doi.org/10.1093/ofid/ofu014.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Opeskin K, Sheorey H, Wright G, Nandurkar H. Favourable outcome of pulmonary zygomycosis in haematological malignancy. Pathology. 2006;38:271–3. https://doi.org/10.1080/00313020600699169.

    Article  PubMed  Google Scholar 

  66. Garbino J, Myers C, Ambrosioni J, Gumy-Pause F. Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. J Pediatr Hematol Oncol. 2010;32:85–7. https://doi.org/10.1097/MPH.0b013e3181c2bdce.

    Article  PubMed  Google Scholar 

  67. Weng TF, Ho MW, Lin HC, Lu MY, Peng CT, Wu KH. Successful treatment of disseminated mixed invasive fungal infection after hematopoietic stem cell transplantation for severe aplastic anemia. Pediatr Transplant. 2012;16:E35–8. https://doi.org/10.1111/j.1399-3046.2010.01406.x.

    Article  Google Scholar 

  68. Kleinotiene G, Posiunas G, Raistenskis J, Zurauskas E, Stankeviciene S, Daugelaviciene V, et al. Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole. Med Oncol. 2013;30:433. https://doi.org/10.1007/s12032-012-0433-3.

    Article  PubMed  Google Scholar 

  69. Mahmood A, Chaump M, Knoll B, Aswad B. Pulmonary zygomycosis in a diabetic patient: treated with pneumonectomy and antifungal agents. R I Med J (2013). 2014;97:44–5.

    Google Scholar 

  70. Moriyama B, Torabi-Parizi P, Pratt AK, Henning SA, Pennick G, Shea YR, et al. Pharmacokinetics of liposomal amphotericin B in pleural fluid. Antimicrob Agents Chemother. 2010;54:1633–5. https://doi.org/10.1128/AAC.01438-09.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Afolayan O, Copeland H, Hargrove R, Zaheer S, Wallen JM. Successful treatment of invasive pulmonary mucormycosis in an immunocompromised patient. Ann Thorac Surg. 2016;101:e117–9. https://doi.org/10.1016/j.athoracsur.2015.09.098.

    Article  Google Scholar 

  72. Baker R.D. The Scope and General Pathology of Human Infection with Fungi, Actinomycetes, and Algae. In: The Pathologic Anatomy of Mycoses. Handbuch der Speziellen Pathologischen Anatomie und Histologie (Atmungswege und Lungen), vol 3 / 5. Berlin, Heidelberg: Springer; 1971. p. 1–11.

  73. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57:1044–50.

    Article  PubMed  CAS  Google Scholar 

  74. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54:S23–34. https://doi.org/10.1093/cid/cir866.

    Article  Google Scholar 

  75. Hamilos G, Samonis G, Kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med. 2011;32:693–702. https://doi.org/10.1055/s-0031-1295717.

    Article  PubMed  Google Scholar 

  76. Dobrilovic N, Wait MA. Pulmonary mucormycosis. Ann Thorac Surg. 2005;79:354. https://doi.org/10.1016/S0003-4975(03)01287-6.

    Article  PubMed  Google Scholar 

  77. Ghuman H, Voelz K. Innate and adaptive immunity to mucorales. J Fungi (Basel). 2017;3(3). https://doi.org/10.3390/jof3030048.

  78. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006;20:581–607. https://doi.org/10.1016/j.idc.2006.06.003 (vi).

    Article  PubMed  Google Scholar 

  79. Jamadar DA, Kazerooni EA, Daly BD, White CS, Gross BH. Pulmonary zygomycosis: CT appearance. J Comput Assist Tomogr. 1995;19:733–8.

    Article  PubMed  CAS  Google Scholar 

  80. Wahba H, Truong MT, Lei X, Kontoyiannis DP, Marom EM. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis. 2008;46:1733–7. https://doi.org/10.1086/587991.

    Article  PubMed  Google Scholar 

  81. Legouge C, Caillot D, Chretien ML, Lafon I, Ferrant E, Audia S, et al. The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? Clin Infect Dis. 2014;58:672–8. https://doi.org/10.1093/cid/cit929.

    Article  PubMed  CAS  Google Scholar 

  82. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18:556–69. https://doi.org/10.1128/CMR.18.3.556-569.2005.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Koszyca B, Ellis D, Toogood I, Byard RW. Fluconazole in the treatment of pulmonary zygomycosis. Mycoses. 1995;38:277–80.

    Article  PubMed  CAS  Google Scholar 

  85. Kontoyiannis DP, Chamilos G, Hassan SA, Lewis RE, Albert ND, Tarrand JJ. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am J Clin Pathol. 2007;127:208–12. https://doi.org/10.1309/7KU5XWURYM0151YN.

    Article  PubMed  Google Scholar 

  86. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012;54:S55–60. https://doi.org/10.1093/cid/cir868.

    Article  Google Scholar 

  87. Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2015. https://doi.org/10.1016/j.cmi.2015.12.006.

    Article  PubMed  Google Scholar 

  88. Rickerts V, Mousset S, Lambrecht E, Tintelnot K, Schwerdtfeger R, Presterl E, et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis. 2007;44:1078–83. https://doi.org/10.1086/512812.

    Article  PubMed  Google Scholar 

  89. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47:503–9. https://doi.org/10.1086/590004.

    Article  PubMed  Google Scholar 

  90. Jung J, Park YS, Sung H, Song JS, Lee SO, Choi SH, et al. Using immunohistochemistry to assess the accuracy of histomorphologic diagnosis of aspergillosis and mucormycosis. Clin Infect Dis. 2015;61:1664–70. https://doi.org/10.1093/cid/civ660.

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This work was not funded by any grants.

Author information

Authors and Affiliations

  1. Department of Hematology, Peking Union Medical College Hospital, Beijing, 100730, China

    Jun Feng

  2. Department of Respiratory Medicine, Peking Union Medical College Hospital, Beijing, China

    Xuefeng Sun

Authors
  1. Jun Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xuefeng Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xuefeng Sun.

Ethics declarations

Conflict of interest

On behalf of all the authors, the corresponding author states that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, J., Sun, X. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection 46, 503–512 (2018). https://doi.org/10.1007/s15010-018-1149-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-018-1149-x

Keywords

Search

Navigation